Cancer research tools and technologies
The infrastructure at the University of Alberta for cancer drug discovery research spans a range of state of the art technologies.
We are involved in finding and validating new cancer targets, solving their 3D structures, identifying drug lead molecules, optimizing their properties and evaluating their activities in biological cells through to (pre)clinical trials.
We welcome you to visit, tour our facilities and talk to motivated scientists about their exciting work.
Figure: Pipeline of lead discovery and development activities
Tours of scientific laboratories are organized by teams of scientists from the University of Alberta who present at our events. Students and postdocs are invited to give give short talks for the public about their exciting cancer research results and to give a public tour of their lab.
|Affinity-based Assays at Molscreen|
|Clinical Trials: Cancer|
|Clinical Trials: Cardiovascular|
|Clinical Trials: NACTRC|
|Magnetic Resonance Imaging|
|Mass Spectrometry: Chemistry|
|Mass Spectrometry: Metabolomics|
|NMR Centre: NANUC|
|Pharmaceutical design: DDIC|